Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / SHS
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
27,368,510
-
Shares change
-
-814,263
-
Total reported value, excl. options
-
$73,887,369
-
Value change
-
-$2,737,104
-
Put/Call ratio
-
0%
-
Number of buys
-
20
-
Number of sells
-
-20
-
Price
-
$2.70
Significant Holders of AC Immune SA - SHS (ACIU) as of Q4 2024
56 filings reported holding ACIU - AC Immune SA - SHS as of Q4 2024.
AC Immune SA - SHS (ACIU) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27,368,510 shares
.
Largest 10 shareholders include BVF INC/IL (19,522,436 shares), BlackRock, Inc. (2,212,522 shares), Redmile Group, LLC (1,034,299 shares), WELLS FARGO & COMPANY/MN (995,636 shares), PLATINUM INVESTMENT MANAGEMENT LTD (952,069 shares), RENAISSANCE TECHNOLOGIES LLC (740,198 shares), NORTHERN TRUST CORP (403,031 shares), DEUTSCHE BANK AG\ (253,375 shares), ACADIAN ASSET MANAGEMENT LLC (198,381 shares), and MORGAN STANLEY (166,555 shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.